| Patents for C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836) |
|---|
| 06/12/2008 | WO2008043601A3 Transdermal therapeutic system with two-phase releasing profile |
| 05/28/2008 | EP1925616A1 Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline |
| 05/21/2008 | CN101184754A Ergoline derivatives and their use as chemokine receptor ligands |
| 05/02/2008 | WO2008049884A1 Process for the preparation of crystal forms of cabergoline via novel stable solvates of cabergoline |
| 04/23/2008 | EP1912984A1 Solvate of cabergoline and preparations of cabergoline form i |
| 04/17/2008 | WO2008043601A2 Transdermal therapeutic system with two-phase releasing profile |
| 03/05/2008 | EP1893611A1 Ergoline derivatives and their use as chemokine receptor ligands |
| 03/04/2008 | US7339060 Form I; dissolving cabergoline in a p-disubstituted benzene to form a solvate, optionally adding a second solvent, crystallization; purification |
| 02/13/2008 | EP1147106B1 Process for the preparation of alkyl mercapto methyl ergoline derivatives |
| 12/20/2007 | US20070293677 Process for the Preparation of Cabergoline |
| 12/05/2007 | EP1861398A2 Preparation of cabergoline |
| 11/28/2007 | EP1858894A1 Improved process for making cabergoline |
| 10/18/2007 | WO2007091039A3 Production of cabergoline and novel polymorphic form thereof |
| 10/18/2007 | US20070244149 Tropane analogs and methods for inhibition of monoamine transport |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 08/23/2007 | US20070197576 Production of Cabergoline and Novel Polymorphic Form Thereof |
| 08/21/2007 | US7258871 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 08/16/2007 | WO2007091039A2 Production of cabergoline and novel polymorphic form thereof |
| 08/16/2007 | CA2640081A1 Production of cabergoline and novel polymorphic form thereof |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |
| 07/12/2007 | US20070161795 Process for isolation of ergot alkaloids from ergot |
| 07/03/2007 | US7238810 Form I; dissolving cabergoline in 4-fluorotoluene to form a solvate, optionally adding a second solvent, crystallization; purification |
| 06/14/2007 | US20070135638 Process for the manufacture of lysergic acid |
| 05/31/2007 | US20070122859 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 05/15/2007 | US7217822 Ergoline-8. beta -carboxamide silylated by a silylation agent of general formula Y Si (R6)(R7)(R8), preferably with trimethylsilyl triflate, under presence of an organic amine |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | CN1956985A Process for the manufacture of lysergic acid |
| 04/19/2007 | DE10212564B4 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne 1-allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine |
| 03/07/2007 | EP1507777A4 Process for preparing crystalline form i of cabergoline |
| 03/06/2007 | US7186837 Form I; dissolving cabergoline in ethylbenzene to form a solvate, optionally adding a second solvent, crystallization; purification |
| 02/14/2007 | CN1300139C Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD |
| 02/01/2007 | WO2007012846A1 Solvate of cabergoline and preparations of cabergoline form i |
| 02/01/2007 | CA2616738A1 Solvate of cabergoline and preparations of cabergoline form i |
| 01/04/2007 | WO2006100492A3 Preparation of cabergoline |
| 01/02/2007 | US7157560 Antibody for use as diagnostic tool in immunoassays |
| 12/28/2006 | WO2006097345A9 Improved process for making cabergoline |
| 12/27/2006 | EP1483264B1 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine |
| 12/21/2006 | US20060287350 Process for making cabergoline |
| 12/14/2006 | US20060281777 Process for preparing crystalline form I of cabergoline |
| 12/07/2006 | WO2006128658A1 Ergoline derivatives and their use as chemokine receptor ligands |
| 12/07/2006 | CA2608702A1 Ergoline derivatives and their use as chemokine receptor ligands |
| 11/15/2006 | EP1720869A2 Process for the preparation of cabergoline |
| 11/08/2006 | EP1718644A1 Process for the manufacture of lysergic acid |
| 10/26/2006 | WO2006065448A3 Topoisomerase inhibitors and prodrugs |
| 10/05/2006 | US20060223998 Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay |
| 10/03/2006 | US7115718 Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD |
| 09/28/2006 | WO2006100492A2 Preparation of cabergoline |
| 09/28/2006 | US20060217555 Preparation of cabergoline |
| 09/28/2006 | US20060217408 Preparation of cabergoline |
| 09/28/2006 | CA2602898A1 Preparation of cabergoline |
| 09/21/2006 | WO2006097345A1 Improved process for making cabergoline |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/07/2006 | US20060199838 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes |
| 07/26/2006 | CN1809358A Polymorphs of cabergoline |
| 07/26/2006 | CN1266149C Use of aspergillus fumigatus in preparing anti inflammatory immunosuppressant |
| 05/26/2006 | WO2006053899A1 Cabergoline preparation method |
| 04/11/2006 | US7026483 Forms of cabergoline |
| 04/06/2006 | WO2005085243A3 Process for the preparation of cabergoline |
| 03/28/2006 | US7019140 Reduction and demethylation of quaternary ammonium salts with nucleophiles, e.g., an alkyl- or toluenesulfonyl halide, of an intemediate from 9,10-dihydrolysergic acid; followed by reacting with a sodium thiomethoxide; purity; efficiency; nontoxic; by-product inhibition |
| 02/01/2006 | EP1620101A2 Polymorphs of cabergoline |
| 02/01/2006 | EP1620100A2 New forms of cabergoline |
| 01/19/2006 | US20060014774 1-allyl ergot alkaloid derivatives, methods for producing the same and the use thereof for preventing and treating migraine |
| 11/10/2005 | WO2005105796A1 Preparation of cabergoline |
| 11/03/2005 | US20050245560 Form I; dissolving cabergoline in ethylbenzene to form a solvate, optionally adding a second solvent, crystallization; purification |
| 11/02/2005 | EP1591445A1 Preparation of cabergoline form I und solvate therof |
| 10/11/2005 | US6953854 Process for preparing crystalline Form I of cabergoline |
| 10/06/2005 | US20050220855 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease |
| 10/05/2005 | CN1221550C Crgstalline form II of cabergoline |
| 09/29/2005 | US20050214353 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease |
| 09/27/2005 | CA2068970C Agent for transdermal administration containing ergoline derivatives |
| 09/15/2005 | WO2005085243A2 Process for the preparation of cabergoline |
| 09/09/2005 | WO2005082902A1 Process for the manufacture of lysergic acid |
| 09/09/2005 | CA2556774A1 Process for the manufacture of lysergic acid |
| 07/28/2005 | DE10043321B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung Use of a transdermal therapeutic system for the treatment of Parkinson's disease, for the treatment and prevention of premenstrual syndrome and Lactationshemmung |
| 07/21/2005 | US20050158240 Method for labeling with tritium |
| 07/20/2005 | CN1642953A Process for preparing crystalline form I of cabergoline |
| 07/20/2005 | CN1642926A Crystalline parecoxib sodium |
| 07/13/2005 | CN1639160A Process for preparing crystalline form I of cabergoline |
| 06/23/2005 | WO2004101510B1 Polymorphs of cabergoline |
| 06/14/2005 | CA2337669C Process for the preparation of alkyl mercapto methyl ergoline derivatives |
| 06/09/2005 | US20050124812 Process for the synthesis of pergolide |
| 05/19/2005 | WO2004094368A3 New forms of cabergoline |
| 05/12/2005 | WO2004101510A3 Polymorphs of cabergoline |
| 04/21/2005 | US20050085499 Crystal structure; solvates; parkinson's disease |
| 02/23/2005 | EP1507777A2 Process for preparing crystalline form i of cabergoline |
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 12/15/2004 | EP1485383A1 Process for preparing crystalline form i of cabergoline |
| 12/15/2004 | EP1485382A2 Process for the synthesis of pergolide |
| 12/15/2004 | EP1485362A1 Crystalline parecoxib sodium |
| 12/08/2004 | EP1483264A2 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine |
| 12/08/2004 | CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant |
| 11/25/2004 | WO2004101510A2 Polymorphs of cabergoline |
| 11/25/2004 | CA2525104A1 Polymorphs of cabergoline |
| 11/23/2004 | CA2125288C Serotoninergic ergoline derivatives |
| 11/10/2004 | EP1280803B1 Crystalline form ii of cabergoline |
| 11/04/2004 | WO2004094368A2 New forms of cabergoline |
| 10/21/2004 | US20040209910 Amorphous physical form of cabergoline substantially free of other physical forms, which is characterized by a given halo x-ray powder diffraction pattern; prepared from solvate form A of cabergoline |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/06/2004 | EP1464644A1 Ergoline derivatives |
| 10/05/2004 | US6800635 Crystallization from solvent at low temperature or slurrying procedure |